期刊文献+

3.0T动态增强磁共振对前列腺癌的定量分析研究 被引量:28

Quantitative diagnostic value of DCE-MRI in prostatic cancer
下载PDF
导出
摘要 目的:探讨3.0T磁共振动态增强(DCE-MRI)定量分析对前列腺癌的诊断价值,并评价Ktrans与Gleason评分的相关性。方法:回顾性分析40例经病理证实的前列腺疾病患者的病例资料,其中前列腺癌(PC)患者28例,前列腺增生(BPH)患者12例,每例患者均行常规MRI和DCE-MRI检查,通过与病理结果对照,在MRI图像上共选取130个样本,分为前列腺癌区、外周带非癌区和中央腺体非癌区三组,在前列腺定量参数伪彩图上取ROI并测量Ktrans、Ve及Kep值,对三组的各参数值分别行方差分析,并检验PC组Ktrans值与Gleason评分的相关性。结果:前列腺癌区的Ktrans、Ve及Kep值分别为(0.62±0.10)min-1、(0.44±0.12)和(1.45±0.25)min-1,外周带非癌区分别为(0.21±0.06)min-1、(0.29±0.65)和(0.76±0.21)min-1,中央区非癌区分别为(0.32±0.09)min-1、(0.34±0.70)和(0.95±0.26)min-1,Ktrans、Ve及Kep值在各组间差异均有统计学意义(F值分别为234.338、32.593及92.462,P值均<0.05);PC组Ktrans、Ve值在不同Gleason评分组间差异有统计学意义(F值分别为6.354、9.217,P值均<0.05),Kep值在不同Gleason评分组间差异无统计学意义(P值>0.05);前列腺癌区的Ktrans值与Gleason评分呈正相关(r=0.533,P<0.05)。结论:3.0TDCEMRI定量分析研究能为PC的诊断提供客观依据。前列腺癌区的Ktrans值与Gleason评分呈正相关,提示定量参数Ktrans值可用于评估PC的恶性程度。 Objective:To study the diagnostic value of quantitative analysis parameters of DCE-MRI in the diagnosis of prostate cancer and to evaluate the correlation between Kt and Gleason scores. Methods: Forty patients with pathologically proved prostate diseases underwent conventional MRI and DCE-MR examinations. They were divided into three groups : cancerous loci, noncancerous area in the peripheral zone and central gland. ROIs were drawn on areas of prostate tissue to measure the values of Ktrans, Vo and Kep. The 3 parameters in the different groups were analyzed, and the correlations between K and Gleason scores were studied. Results:The Ktrans ,Ve and Kep valuesof cancerous loci were (0.62±0.10)/min, (0.44 ± 0. 12) and ( 1.45± 0. 25 )/min, respectively, while, for noncancerous area in the peripheral zone were (0. 21± 0.06)/min, (0.29 ± 0.65 ), (0.76±0.21)/min, respectively, and for noncancerous area in the central gland were (0.32 ± 0.09)/rain, (0.34±0.70), (0.95±0.26 )/min, respectively. The differences between K , Vo and Kep values of the three groups were statistically significant (F= 234. 338,32. 593 and 92. 462, respectively; P〈0.05). Significant correlation was found between K and Gleason score (r= 0. 533, P〈0.05). Conclusion: The differences of K , Vo and Kep among the three groups (cancerous foci,noncancerous area in the peripheral zone and central gland) are statistically significant. 3.0T DCE-MRI quantitative analysis plays an important role in the diagnosis of prostate cancer. Positive correlation is found be- tween K and Gleason score. Ktrans can be used for evaluating the degree of malignancy of prostate cancer.
出处 《放射学实践》 2014年第5期477-481,共5页 Radiologic Practice
基金 国家自然科学基金(81370039) 西京医院临床高新技术新业务助推项目(XJGX13LC11)
关键词 前列腺肿瘤 磁共振成像 前列腺增生 Prostate neoplasms Magnetic resonance imaging Prostatic hyperplasia
  • 相关文献

参考文献16

  • 1van DFA,der Graaf MV,Engelbmcht MR,et al. Combined quanti- tative dynamic contrast-enhanced MR imaging and i H-MR spec-troscopic imaging of human prostate cance[J]. J Magn Reson Ima- ging,2004,20(2) :279-287.
  • 2Sehlemmer HP, Merkle J, Grohholz R, et al. Canpreo-perative con- trast-enhanced dynamic MR imaging for prostate cancer predict- microvessel density in prostatectomy specimens[J]. Eur Radiol, 2004,14(2) :309-317.
  • 3Langer DL, van der Kwast TH, Evans AJ, et al. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative Tz, diffusion-weighted imaging, and dynamic con- trast enhanced MRI[J]. J Magn Reson Imaging, 2009,30 (2) : 327- 334.
  • 4Padhani AR,Gapinski CJ, Macvicar DA, et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA[-J]. Clin Radiol, 2000,55(2) :99-109.
  • 5Kozlowski P, Chang SD, Jones EC, et al. Combined difusion- weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosiseorrelation with biopsy and histopathology[J]. J Magn Reson Imaging, 2006,24(1) : 108-113.
  • 6Jackson AS,Reinsberg SA, Sohaib SA, et al. Dynamic contraster- damaced MRI for prostate cancer localization[J]. Br J Radiol, 2009,82(974) :148-156.
  • 7Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical stag- ing[J]. J 1Aro1,1974,111(1) :58-64.
  • 8Epstein JI, Allsbrook WC Jr, Amin MB, et al. The 2005 interna- tional society of urological pathology (ISUP) consensus confer-enee on Gleason grading of prostatiearcinoma[J]. Am J Surg Pathol,2005,29(9) :1228-1242.
  • 9Wang L, Mazaheri Y, Zhang J, et al. Assessment ofbiologie ag- gressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostateetomy[J]. Radiology, 2008,246(1) : 168-176.
  • 10周桥.前列腺癌Gleason分级[J].中华病理学杂志,2005,34(4):240-243. 被引量:44

二级参考文献17

  • 1Humphrey P. Prostate pathology. Chicago: ASCP Press, 2003. 338-375.
  • 2Eble JN, Sauter G, Sesterhen IA. Pathology and genetics of the urinary system and male genital organs. Lyon: IARC Press, 2004. 159-215.
  • 3Epstein JI. The prostate and seminal vesicles. In: Mills SE, ed. Sternberg's diagnostic surgical pathology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2004. 2083-2132.
  • 4Humphrey PA. Gleason grading and prognostic factors in carcinoma of the prostate. Mod Pathol, 2004, 17:292-305.
  • 5Srigley JR, Amin MB, Bostwick DG, et al. Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland: a basis for checklists. Cancer Committee. Arch Pathol Lab Med, 2000,124:1034-1039.
  • 6Kronz JD, Silberman MA, Allsbrook WC Jr, et al. Pathology residents' use of a Web-based tutorial to improve Gleason grading of prostate carcinoma on needle biopsies. Hum Pathol, 2000, 31:1044-1050.
  • 7Kronz JD, Silberman MA, Allsbrook WC Jr, et al. A web-based tutorial improves practicing pathologists' Gleason grading of images of prostate carcinoma specimens obtained by needle biopsy: validation of a new medical education paradigm. Cancer, 2000, 89:1818-1823.
  • 8Gleason DF. Histologic grading and clinical staging of prostate carcinoma. In : Tannenbaum M, ed. Urologic pathology: the prostate. Philadelphia: Lea & Fibiger, 1977.171-198.
  • 9Kovi J. Surgical pathology of the prostate. Boca Raton: CRC Press Inc, 1989. 195-200.
  • 10Deshmukh N, Foster CS. Grading prostate cancer. In: Foster CS, ed.Pathology of the prostate. Philadelphia: WB Saunders, 1998. 191-227.

共引文献43

同被引文献207

引证文献28

二级引证文献231

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部